CDKN2A and melanoma: Additionally, individuals with CDKN2A PVs have an increased probability of multiple primary melanomas: one study reported a 23% incidence of second melanoma primary diagnosed within 5 years of the first, representing a 10-fold increase over that of melanoma patients without CDKN2A PVs (39).